Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2019-06-18 Sale | 2022-05-13 5:24 pm | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 10,000 | $55 | $550,000 | 64,233 (Indirect Direct) | View |
| 2022-04-08 Sale | 2022-04-08 6:56 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 86,348 | $64.37 | $5,558,051 | 45,339 (Direct) | View |
| 2022-03-16 Sale | 2022-03-18 8:12 pm | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 226,670 | $60.1 | $13,623,979 | 76,815 (Indirect Direct) | View |
| 2022-03-07 Sale | 2022-03-09 9:49 pm | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 20,000 | $53.14 | $1,062,750 | 69,663 (Indirect Direct) | View |
| 2022-03-02 Sale | 2022-03-04 6:05 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 8,037 | $56.28 | $452,313 | 23,104 (Direct) | View |
| 2022-02-23 Sale | 2022-02-25 7:09 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 4,046 | $52.27 | $211,468 | 46,954 (Direct) | View |
| 2022-02-23 Sale | 2022-02-25 7:08 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 7,906 | $52.21 | $412,810 | 61,152 (Direct) | View |
| 2022-02-23 Sale | 2022-02-25 7:06 pm | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 7,906 | $51.98 | $410,933 | 15,813 (Direct) | View |
| 2022-02-23 Sale | 2022-02-25 7:04 pm | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 7,454 | $51.97 | $387,349 | 14,910 (Direct) | View |
| 2022-02-23 Sale | 2022-02-25 7:01 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 22,589 | $51.98 | $1,174,074 | 1,139,647 (Direct) | View |
| 2022-02-18 Sale | 2022-02-23 7:08 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 4,177 | $55.29 | $230,958 | 35,635 (Direct) | View |
| 2022-02-18 Sale | 2022-02-23 7:07 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 11,139 | $55.29 | $615,827 | 56,478 (Direct) | View |
| 2022-02-18 Sale | 2022-02-23 7:05 pm | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 11,139 | $55.4 | $617,100 | 11,139 (Direct) | View |
| 2022-02-18 Sale | 2022-02-23 7:02 pm | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 10,443 | $55.4 | $578,506 | 10,443 (Direct) | View |
| 2022-02-18 Sale | 2022-02-23 7:00 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 27,847 | $55.39 | $1,542,413 | 1,122,315 (Direct) | View |
| 2022-01-18 Sale | 2022-01-20 4:07 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 6,223 | $42.03 | $261,553 | 23,104 (Direct) | View |
| 2022-01-08 Sale | 2022-01-11 8:08 pm | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 6,870 | $40.76 | $280,020 | 29,327 (Direct) | View |
| 2022-01-08 Sale | 2022-01-11 8:06 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 20,948 | $40.78 | $854,255 | 45,339 (Direct) | View |
| 2022-01-08 Sale | 2022-01-11 8:04 pm | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 19,639 | $40.77 | $800,774 | 0 (Direct) | View |
| 2022-01-08 Sale | 2022-01-11 8:02 pm | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 19,639 | $40.76 | $800,420 | 0 (Direct) | View |
| 2022-01-08 Sale | 2022-01-11 8:00 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 41,896 | $40.78 | $1,708,429 | 1,094,467 (Direct) | View |
| 2021-12-21 Sale | 2021-12-23 7:02 pm | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 176,863 | $47.56 | $8,412,278 | 0 (Direct) | View |
| 2021-12-21 Sale | 2021-12-23 7:00 pm | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 175,000 | $47.59 | $8,328,664 | 10,837 (Direct) | View |
| 2021-10-15 Sale | 2021-10-19 4:26 pm | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 13,448 | $40.86 | $549,551 | 45,339 (Direct) | View |
| 2021-10-14 Sale | 2021-10-18 6:00 pm | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 50,000 | $40 | $2,000,000 | 1,133,392 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2019-06-18 Exercise | 2022-05-13 5:24 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | MARCUS JOEL S Director | 14,189 | $0 | 64,233 (Direct) | View |
| 2022-04-20 Option Award | 2022-04-21 4:54 pm | 2023-04-20 2032-04-20 | Intra-Cellular Therapies Inc. | ITCI | Salas Eduardo Rene Director | 20,000 | $0 | 20,000 (Direct) | View |
| 2022-04-08 Exercise | 2022-04-08 6:56 pm | N/A 2029-01-07 | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 86,348 | $0 | 45,339 (Direct) | View |
| 2022-04-08 Exercise | 2022-04-08 6:56 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 86,348 | $12.73 | 45,339 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 4:11 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 126 | $61.19 | 8,935 (Direct) | View |
| 2022-03-31 Option Award | 2022-04-04 4:08 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 257 | $61.19 | 77,072 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 4:15 pm | N/A 2032-03-09 | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 39,950 | $0 | 39,950 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 4:13 pm | N/A 2032-03-09 | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 39,950 | $0 | 39,950 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 4:07 pm | N/A 2032-03-09 | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 39,950 | $0 | 39,950 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 4:06 pm | N/A 2032-03-09 | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 30,362 | $0 | 30,362 (Direct) | View |
| 2022-03-10 Option Award | 2022-03-14 4:03 pm | N/A 2032-03-09 | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 111,863 | $0 | 111,863 (Direct) | View |
| 2022-03-09 Exercise | 2022-03-10 4:13 pm | N/A 2022-04-30 | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 38,925 | $0 | 1,133,392 (Direct) | View |
| 2022-03-09 Exercise | 2022-03-10 4:13 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 38,925 | $2.84 | 1,133,392 (Direct) | View |
| 2022-02-23 Exercise | 2022-02-25 7:09 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 7,906 | $0 | 46,954 (Direct) | View |
| 2022-02-23 Exercise | 2022-02-25 7:08 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 7,906 | $0 | 61,152 (Direct) | View |
| 2022-02-23 Exercise | 2022-02-25 7:06 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 7,906 | $0 | 15,813 (Direct) | View |
| 2022-02-23 Exercise | 2022-02-25 7:04 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 7,454 | $0 | 14,910 (Direct) | View |
| 2022-02-23 Exercise | 2022-02-25 7:01 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 22,589 | $0 | 1,139,647 (Direct) | View |
| 2022-02-18 Exercise | 2022-02-23 7:08 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 8,354 | $0 | 35,635 (Direct) | View |
| 2022-02-18 Exercise | 2022-02-23 7:07 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 11,139 | $0 | 56,478 (Direct) | View |
| 2022-02-18 Exercise | 2022-02-23 7:05 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 11,139 | $0 | 11,139 (Direct) | View |
| 2022-02-18 Exercise | 2022-02-23 7:02 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 10,443 | $0 | 10,443 (Direct) | View |
| 2022-02-18 Exercise | 2022-02-23 7:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 27,847 | $0 | 1,122,315 (Direct) | View |
| 2022-01-08 Exercise | 2022-01-11 8:08 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Durgam Suresh K. Chief Medical Officer | 13,093 | $0 | 29,327 (Direct) | View |
| 2022-01-08 Exercise | 2022-01-11 8:06 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 20,948 | $0 | 45,339 (Direct) | View |
| 2022-01-08 Exercise | 2022-01-11 8:04 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 19,639 | $0 | 0 (Direct) | View |
| 2022-01-08 Exercise | 2022-01-11 8:02 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 19,639 | $0 | 0 (Direct) | View |
| 2022-01-08 Exercise | 2022-01-11 8:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 41,896 | $0 | 1,094,467 (Direct) | View |
| 2021-12-31 Option Award | 2022-01-04 9:52 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 148 | $52.34 | 8,809 (Direct) | View |
| 2021-12-31 Option Award | 2022-01-04 9:50 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 300 | $52.34 | 303,485 (Direct) | View |
| 2021-12-21 Exercise | 2021-12-23 7:02 pm | N/A 2024-07-29 | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 176,863 | $0 | 0 (Direct) | View |
| 2021-12-21 Exercise | 2021-12-23 7:02 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 63,717 | $15.73 | 0 (Direct) | View |
| 2021-12-21 Exercise | 2021-12-23 7:02 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 25,000 | $13.86 | 0 (Direct) | View |
| 2021-12-21 Exercise | 2021-12-23 7:02 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Halstead Michael VP | 88,146 | $17.57 | 0 (Direct) | View |
| 2021-12-21 Exercise | 2021-12-23 7:00 pm | N/A 2024-06-30 | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 175,000 | $0 | 10,837 (Direct) | View |
| 2021-12-21 Exercise | 2021-12-23 7:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 52,880 | $15.73 | 10,837 (Direct) | View |
| 2021-12-21 Exercise | 2021-12-23 7:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 50,000 | $16.86 | 10,837 (Direct) | View |
| 2021-12-21 Exercise | 2021-12-23 7:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Hineline Lawrence J. CFO | 72,120 | $17.57 | 10,837 (Direct) | View |
| 2021-10-15 Exercise | 2021-10-19 4:26 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Neumann Mark EVP Chief Commercial Officer | 13,448 | $0 | 45,339 (Direct) | View |
| 2021-10-14 Exercise | 2021-10-18 6:00 pm | N/A 2022-04-30 | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 1,075 | $0 | 1,133,392 (Direct) | View |
| 2021-10-14 Exercise | 2021-10-18 6:00 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | Mates Sharon CEO Chairman | 1,075 | $2.84 | 1,133,392 (Direct) | View |
| 2021-09-30 Option Award | 2021-10-04 5:43 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | LERNER RICHARD A Director | 402 | $37.28 | 108,093 (Indirect) | View |
| 2021-09-30 Option Award | 2021-10-04 4:24 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | RIGGS RORY B Director | 422 | $37.28 | 303,185 (Direct) | View |
| 2021-09-30 Option Award | 2021-10-04 4:23 pm | N/A N/A | Intra-Cellular Therapies Inc. | ITCI | VAN NOSTRAND ROBERT L Director | 215 | $37.28 | 8,661 (Direct) | View |